A 3′ untranslated region variant in FMR1 eliminates neuronal activity-dependent translation of FMRP by disrupting binding of the RNA-binding protein HuR

• Published in: Proceedings of the National Academy of Sciences - PNAS 2015-11, Vol.112 (47), p.E6553-E6561
• Main Authors: Suhl, Joshua A, Muddashetty, Ravi S, Anderson, Bart R, Ifrim, Marius F, Visootsak, Jeannie, Bassell, Gary J, Warren, Stephen T
• Format: Article
• Language: English
• Subjects: 3' Untranslated Regions - genetics; Alleles; Animals; Autism; Base Sequence; Biological Sciences; Biotinylation; Cells, Cultured; Dendrites - metabolism; ELAV-Like Protein 1 - metabolism; Electrophoretic Mobility Shift Assay; Fragile X Mental Retardation Protein - genetics; Fragile X Mental Retardation Protein - metabolism; Genes, Reporter; Genetic Loci; Humans; Learning disabilities; Luciferases - metabolism; Male; Mice; Molecular Sequence Data; Mutation; Neurons - metabolism; PNAS Plus; Protein Binding; Protein Biosynthesis; Proteins; Receptors, Glutamate - metabolism; RNA Stability; RNA, Messenger - genetics; RNA, Messenger - metabolism; RNA-protein interactions; Rodents; Sequence Alignment; Signal Transduction - genetics; Synapses - metabolism; Tandem Mass Spectrometry
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.1514260112

Fragile X syndrome is a common cause of intellectual disability and autism spectrum disorder. The gene underlying the disorder, fragile X mental retardation 1 (FMR1), is silenced in most cases by a CGG-repeat expansion mutation in the 5' untranslated region (UTR). Recently, we identified a variant located in the 3'UTR of FMR1 enriched among developmentally delayed males with normal repeat lengths. A patient-derived cell line revealed reduced levels of endogenous fragile X mental retardation protein (FMRP), and a reporter containing a patient 3'UTR caused a decrease in expression. A control reporter expressed in cultured mouse cortical neurons showed an expected increase following synaptic stimulation that was absent when expressing the patient reporter, suggesting an impaired response to neuronal activity. Mobility-shift assays using a control RNA detected an RNA-protein interaction that is lost with the patient RNA, and HuR was subsequently identified as an associated protein. Cross-linking immunoprecipitation experiments identified the locus as an in vivo target of HuR, supporting our in vitro findings. These data suggest that the disrupted interaction of HuR impairs activity-dependent translation of FMRP, which may hinder synaptic plasticity in a clinically significant fashion.